Dynamic SPECT imaging after injection of the benzodiazepine receptor ligand [123I]iomazenil in healthy human subjects

Scott W. Woods, John P. Seibyl, Andrew W. Goddard, Holley M. Dey, Sami S. Zoghbi, Mark Germine, Ronald M. Baldwin, Eileen O. Smith, Dennis S. Charney, George R. Heninger, Paul B. Hoffer, Robert B. Innis

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Previous work suggests that iomazenil (formerly known as Ro 16-0154) is a useful ligand for static imaging of the benzodiazepine (BZ) receptor with single photon emission computed tomography (SPECT). The present study evaluated the feasibility of dynamic SPECT imaging of cerebral radioactivity following intravenous [123I]iomazenil injection in healthy human subjects, in preparation for future receptor quantitation studies. Maximal brain uptake was reached approximately 25-30 minutes after i.v. administration of the radioligand and represented approximately 12% of the injected dose. The regional distribution of radioactive densities was consistent with the known distribution of BZ receptors in human brain, with highest uptake localized over the occipital area. Washout of cortical radioactivity was regionally variable but relatively slow, with a half-life of approximately 4 hours after the time of peak radioactivity. In summary, [123I]iomazenil is a promising SPECT radioligand for the BZ receptor, with high brain uptake, relatively slow washout of radioactivity and appropriate regional distribution.

Original languageEnglish (US)
Pages (from-to)67-77
Number of pages11
JournalPsychiatry Research - Neuroimaging
Volume45
Issue number2
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

GABA-A Receptors
Single-Photon Emission-Computed Tomography
Radioactivity
Healthy Volunteers
Ligands
Injections
Brain
Feasibility Studies
Half-Life
iomazenil

Keywords

  • brain imaging
  • flumazenil
  • occipital lobes
  • Ro 16-0154
  • Single photon emission computed tomography

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Radiology Nuclear Medicine and imaging
  • Biological Psychiatry
  • Psychology(all)

Cite this

Dynamic SPECT imaging after injection of the benzodiazepine receptor ligand [123I]iomazenil in healthy human subjects. / Woods, Scott W.; Seibyl, John P.; Goddard, Andrew W.; Dey, Holley M.; Zoghbi, Sami S.; Germine, Mark; Baldwin, Ronald M.; Smith, Eileen O.; Charney, Dennis S.; Heninger, George R.; Hoffer, Paul B.; Innis, Robert B.

In: Psychiatry Research - Neuroimaging, Vol. 45, No. 2, 1992, p. 67-77.

Research output: Contribution to journalArticle

Woods, SW, Seibyl, JP, Goddard, AW, Dey, HM, Zoghbi, SS, Germine, M, Baldwin, RM, Smith, EO, Charney, DS, Heninger, GR, Hoffer, PB & Innis, RB 1992, 'Dynamic SPECT imaging after injection of the benzodiazepine receptor ligand [123I]iomazenil in healthy human subjects', Psychiatry Research - Neuroimaging, vol. 45, no. 2, pp. 67-77. https://doi.org/10.1016/0925-4927(92)90001-K
Woods, Scott W. ; Seibyl, John P. ; Goddard, Andrew W. ; Dey, Holley M. ; Zoghbi, Sami S. ; Germine, Mark ; Baldwin, Ronald M. ; Smith, Eileen O. ; Charney, Dennis S. ; Heninger, George R. ; Hoffer, Paul B. ; Innis, Robert B. / Dynamic SPECT imaging after injection of the benzodiazepine receptor ligand [123I]iomazenil in healthy human subjects. In: Psychiatry Research - Neuroimaging. 1992 ; Vol. 45, No. 2. pp. 67-77.
@article{943e8e99261848119be35850743085e5,
title = "Dynamic SPECT imaging after injection of the benzodiazepine receptor ligand [123I]iomazenil in healthy human subjects",
abstract = "Previous work suggests that iomazenil (formerly known as Ro 16-0154) is a useful ligand for static imaging of the benzodiazepine (BZ) receptor with single photon emission computed tomography (SPECT). The present study evaluated the feasibility of dynamic SPECT imaging of cerebral radioactivity following intravenous [123I]iomazenil injection in healthy human subjects, in preparation for future receptor quantitation studies. Maximal brain uptake was reached approximately 25-30 minutes after i.v. administration of the radioligand and represented approximately 12{\%} of the injected dose. The regional distribution of radioactive densities was consistent with the known distribution of BZ receptors in human brain, with highest uptake localized over the occipital area. Washout of cortical radioactivity was regionally variable but relatively slow, with a half-life of approximately 4 hours after the time of peak radioactivity. In summary, [123I]iomazenil is a promising SPECT radioligand for the BZ receptor, with high brain uptake, relatively slow washout of radioactivity and appropriate regional distribution.",
keywords = "brain imaging, flumazenil, occipital lobes, Ro 16-0154, Single photon emission computed tomography",
author = "Woods, {Scott W.} and Seibyl, {John P.} and Goddard, {Andrew W.} and Dey, {Holley M.} and Zoghbi, {Sami S.} and Mark Germine and Baldwin, {Ronald M.} and Smith, {Eileen O.} and Charney, {Dennis S.} and Heninger, {George R.} and Hoffer, {Paul B.} and Innis, {Robert B.}",
year = "1992",
doi = "10.1016/0925-4927(92)90001-K",
language = "English (US)",
volume = "45",
pages = "67--77",
journal = "Psychiatry Research - Neuroimaging",
issn = "0925-4927",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Dynamic SPECT imaging after injection of the benzodiazepine receptor ligand [123I]iomazenil in healthy human subjects

AU - Woods, Scott W.

AU - Seibyl, John P.

AU - Goddard, Andrew W.

AU - Dey, Holley M.

AU - Zoghbi, Sami S.

AU - Germine, Mark

AU - Baldwin, Ronald M.

AU - Smith, Eileen O.

AU - Charney, Dennis S.

AU - Heninger, George R.

AU - Hoffer, Paul B.

AU - Innis, Robert B.

PY - 1992

Y1 - 1992

N2 - Previous work suggests that iomazenil (formerly known as Ro 16-0154) is a useful ligand for static imaging of the benzodiazepine (BZ) receptor with single photon emission computed tomography (SPECT). The present study evaluated the feasibility of dynamic SPECT imaging of cerebral radioactivity following intravenous [123I]iomazenil injection in healthy human subjects, in preparation for future receptor quantitation studies. Maximal brain uptake was reached approximately 25-30 minutes after i.v. administration of the radioligand and represented approximately 12% of the injected dose. The regional distribution of radioactive densities was consistent with the known distribution of BZ receptors in human brain, with highest uptake localized over the occipital area. Washout of cortical radioactivity was regionally variable but relatively slow, with a half-life of approximately 4 hours after the time of peak radioactivity. In summary, [123I]iomazenil is a promising SPECT radioligand for the BZ receptor, with high brain uptake, relatively slow washout of radioactivity and appropriate regional distribution.

AB - Previous work suggests that iomazenil (formerly known as Ro 16-0154) is a useful ligand for static imaging of the benzodiazepine (BZ) receptor with single photon emission computed tomography (SPECT). The present study evaluated the feasibility of dynamic SPECT imaging of cerebral radioactivity following intravenous [123I]iomazenil injection in healthy human subjects, in preparation for future receptor quantitation studies. Maximal brain uptake was reached approximately 25-30 minutes after i.v. administration of the radioligand and represented approximately 12% of the injected dose. The regional distribution of radioactive densities was consistent with the known distribution of BZ receptors in human brain, with highest uptake localized over the occipital area. Washout of cortical radioactivity was regionally variable but relatively slow, with a half-life of approximately 4 hours after the time of peak radioactivity. In summary, [123I]iomazenil is a promising SPECT radioligand for the BZ receptor, with high brain uptake, relatively slow washout of radioactivity and appropriate regional distribution.

KW - brain imaging

KW - flumazenil

KW - occipital lobes

KW - Ro 16-0154

KW - Single photon emission computed tomography

UR - http://www.scopus.com/inward/record.url?scp=0026448375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026448375&partnerID=8YFLogxK

U2 - 10.1016/0925-4927(92)90001-K

DO - 10.1016/0925-4927(92)90001-K

M3 - Article

C2 - 1336860

AN - SCOPUS:0026448375

VL - 45

SP - 67

EP - 77

JO - Psychiatry Research - Neuroimaging

JF - Psychiatry Research - Neuroimaging

SN - 0925-4927

IS - 2

ER -